Clinical Trial Update: A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating a triplet chemotherapy regimen of irinotecan, oxaliplatin, and TS-1 in untreated metastatic gastric cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Eloxatin (oxaliplatin)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED